PubMed-compiled information sheet
This sheet was compiled from PubMed (NIH) abstracts using AI assistance. Every factual claim is cited to a real PubMed article (see the source list). It has not yet been human-reviewed — confirm with a healthcare provider before use.
Compiled from 17 PubMed articles · model: gemma4:31b
Summary
Background
Active compounds
Mechanism of action
Clinical evidence
Chromium supplementation improved glycosylated hemoglobin (HbA1c) by -0.6% and fasting glucose by -1.0 mmol/l in participants with type 2 diabetes, though no benefit was found in individuals without diabetes [PMID:17519436].
Chromium picolinate consumption resulted in significantly decreased Apo B levels [PMID:33183560].
Daily intake of a yeast chromium supplement (125 mcg/d) for three months led to a decrease in the negative part of the glucose tolerance curve in 40% of patients [PMID:2484361].
A supplement containing chromium, magnesium, and herbal extracts significantly improved performance on tasks of attention and working memory in stressed adults [PMID:41194549].
Safety & adverse effects
Dosage & administration
Evidence summary
PubMed sources
- 1.PMID: 38024820 (2023) — A comparative study to assess the use of chromium in type 2 diabetes mellitus. · Journal of medicine and life
- 2.PMID: 33183560 (2020) — The effect of chromium supplementation on apolipoproteins: A systematic review and meta-analysis of randomized clinical trials. · Clinical nutrition ESPEN
- 3.PMID: 17519436 (2007) — Effect of chromium supplementation on glucose metabolism and lipids: a systematic review of randomized controlled trials. · Diabetes care
- 4.PMID: 41194549 (2025) — Effects of a Scutellaria baicalensis/Crataegus laevigata, magnesium and chromium supplement on stressed individuals: A randomised, double-blind, placebo-controlled, crossover trial. · Journal of psychopharmacology (Oxford, England)
- 5.PMID: 35940431